Study of insulin resistance in relation to serum IGF-I levels in subjects with different degrees of glucose tolerance
- PMID: 19902049
- PMCID: PMC2772007
- DOI: 10.4103/0973-3930.43100
Study of insulin resistance in relation to serum IGF-I levels in subjects with different degrees of glucose tolerance
Abstract
Aim: We studied the correlations between fasting and post-lunch serum IGF-I concentrations, and insulin resistance and insulin sensitivity in subjects with various degrees of glucose tolerance.
Materials and methods: A total of 12 nondiabetic subjects, 09 subjects with impaired glucose tolerance (IGT) and 18 patients with newly diagnosed type-2 diabetes of either sex (mean age, 46 years) were recruited. None of the participants received any drug treatment at the commencement of the study. Fasting as well as post-lunch blood samples were collected from all the subjects and anthropometric and biochemical parameters were analyzed.
Results: Fasting serum IGF-I concentrations were negatively correlated with fasting serum glucose, insulin, C-peptide, triglycerides, total LDL and VLDL cholesterol, homeostatic model assessment of insulin resistance (HOMA-IR), and age. Fasting serum IGF-I concentrations were positively correlated with fasting blood HDL cholesterol and homeostatic model assessment of insulin sensitivity (HOMA-S) in only diabetic subjects. Post-lunch serum IGF-I concentrations were positively correlated with HDL and LDL cholesterol. Correlations with HOMA-S with these metabolic anthropometric variables were of similar magnitude and direction as that of IGF-I concentrations. IGF-I concentrations were significantly lower in the subjects with World Health Organization-defined metabolic syndrome compared with the subjects without metabolic syndrome (P < 0.0001).
Conclusions: Our data indicate that IGF-I could be a useful marker in the insulin resistance syndrome. The post-lunch low-IGF-I levels help in better identification of subjects at risk for type-2 diabetes mellitus and cardiovascular disease.
Keywords: Diabetes mellitus; insulin like growth factor-I (IGF-I); insulin resistance syndrome.
Conflict of interest statement
References
-
- Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607. - PubMed
-
- Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, et al. Liver-specific IGF-1gene deletion leads to muscle insulin insensitivity. Diabetes. 2001;50:1110–18. - PubMed
-
- Sjogren K, Wallenius K, Liu JL, Bohlooly- YM, Pacini G, Svensson L, et al. Liver-derived IGF-I is of importancefor normal carbohydrate andlipid metabolism. Diabetes. 2001;50:1539–45. - PubMed
-
- Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 1996;45:91–100. - PubMed
LinkOut - more resources
Full Text Sources